EVERSANA adds powerful predictive analytics platform

EVERSANA, a leading provider of commercial services to the life science industry, has acquired HVH Precision Analytics and its predictive analytics platform. Previously owned by Havas Health & You and Perspecta, and leveraging analytic expertise originally honed to support military and U.S. intelligence community, company executives say the artificial intelligence (AI) and machine learning platform has been refined to transform the healthcare sector. 

With the acquisition, EVERSANA management says the company now has the best-in-class ability to analyze data quickly, make predictions and perform smarter, faster actions for life science companies.

“This acquisition marks a transformative moment for EVERSANA and our clients,” says Jim Lang, CEO of EVERSANA. “Our integrated commercial services are now powered by a military grade analytics platform which will optimize every corner of our operation, ranging from our strategies to ensure long-term market access and revenue management to our services improving patient adherence.”

According to Steve Costalas, CEO of HVH Precision Analytics, “The value brought by data and analytics is long overdue within the pharmaceutical industry. Our technology and talented team are at the forefront of the industry and are already propelling faster analysis and actions for EVERSANA clients. The fit is seamless, and we are onboarding new programs right now.”